IL147581D0 - New interferon beta-like molecules - Google Patents

New interferon beta-like molecules

Info

Publication number
IL147581D0
IL147581D0 IL14758100A IL14758100A IL147581D0 IL 147581 D0 IL147581 D0 IL 147581D0 IL 14758100 A IL14758100 A IL 14758100A IL 14758100 A IL14758100 A IL 14758100A IL 147581 D0 IL147581 D0 IL 147581D0
Authority
IL
Israel
Prior art keywords
molecules
interferon beta
new interferon
new
beta
Prior art date
Application number
IL14758100A
Original Assignee
Maxygen Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DKPA199901197 priority Critical
Priority to US16078299P priority
Priority to DKPA199901691 priority
Priority to DKPA200000194 priority
Priority to DKPA200000363 priority
Priority to DKPA200000642 priority
Application filed by Maxygen Aps filed Critical Maxygen Aps
Priority to PCT/DK2000/000471 priority patent/WO2001015736A2/en
Publication of IL147581D0 publication Critical patent/IL147581D0/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/215IFN-beta
IL14758100A 1999-08-27 2000-08-25 New interferon beta-like molecules IL147581D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
DKPA199901197 1999-08-27
US16078299P true 1999-10-21 1999-10-21
DKPA199901691 1999-11-26
DKPA200000194 2000-02-07
DKPA200000363 2000-03-07
DKPA200000642 2000-04-14
PCT/DK2000/000471 WO2001015736A2 (en) 1999-08-27 2000-08-25 Interferon-beta conjugates

Publications (1)

Publication Number Publication Date
IL147581D0 true IL147581D0 (en) 2002-08-14

Family

ID=27545189

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14758100A IL147581D0 (en) 1999-08-27 2000-08-25 New interferon beta-like molecules

Country Status (13)

Country Link
EP (1) EP1328295A2 (en)
JP (1) JP2003527090A (en)
CN (1) CN1501815A (en)
AU (1) AU6687000A (en)
BR (1) BR0013638A (en)
CA (1) CA2380760A1 (en)
CZ (1) CZ2002521A3 (en)
HU (1) HU0302674A2 (en)
IL (1) IL147581D0 (en)
MX (1) MXPA02001969A (en)
NO (1) NO20020929L (en)
SK (1) SK2942002A3 (en)
WO (1) WO2001015736A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01003790A (en) 1998-10-16 2002-09-18 Biogen Inc Interferon-beta fusion proteins and uses.
LT2599503T (en) * 1998-10-16 2017-06-26 Biogen Ma Inc. Polymer conjugates of interferon beta-1A and uses thereof
US7144574B2 (en) 1999-08-27 2006-12-05 Maxygen Aps Interferon β variants and conjugates
US7431921B2 (en) 2000-04-14 2008-10-07 Maxygen Aps Interferon beta-like molecules
AU1210702A (en) * 2000-11-02 2002-05-15 Maxygen Aps New multimeric interferon beta polypeptides
HU0303251A2 (en) * 2001-02-27 2003-12-29 Maxygen Aps Beta-interferon-like molecules
AU2002254174A1 (en) * 2001-03-13 2002-09-24 Vical Incorporated Interferon-beta polynucleotide therapy for autoimmune and inflammatory diseases
EP1476181B1 (en) 2002-01-18 2016-03-23 Biogen MA Inc. Polyalkylene polymer compounds and uses thereof
WO2004020468A2 (en) * 2002-08-28 2004-03-11 Maxygen Aps Interferon beta-like molecules for treatment of cancer
US9125880B2 (en) * 2002-12-26 2015-09-08 Mountain View Pharmaceuticals, Inc. Polymer conjugates of interferon-beta with enhanced biological potency
CN101880326B (en) * 2003-08-25 2018-02-16 东丽株式会社 Interferon beta compound
EP1674113A1 (en) * 2004-12-22 2006-06-28 F. Hoffmann-La Roche Ag Conjugates of insulin-like growth factor-1 (IGF-1) and poly(ethylene glycol)
US7625555B2 (en) 2007-06-18 2009-12-01 Novagen Holding Corporation Recombinant human interferon-like proteins
CL2008002399A1 (en) * 2007-08-16 2009-01-02 Pharmaessentia Corp Substantially pure conjugate having a polymer portion, a proteinaceous portion (interferon alfa 2b) and an aliphatic binder 1 to 10 carbon atoms, useful in the treatment of hepatitis c bo.
CN104043112B (en) * 2014-07-01 2016-03-30 哈药集团生物工程有限公司 Containing recombinant human interferon α-2b (Pseudomonas) ointment pharmaceutical composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2524586B2 (en) * 1985-06-26 1996-08-14 シタス コーポレイション Polymer - solubilization of a pharmaceutical composition for the protein utilizing a junction
US5206344A (en) * 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US4917888A (en) * 1985-06-26 1990-04-17 Cetus Corporation Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation
US4904584A (en) * 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides
US5218092A (en) * 1988-09-29 1993-06-08 Kyowa Hakko Kogyo Co., Ltd. Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains
US5738846A (en) * 1994-11-10 1998-04-14 Enzon, Inc. Interferon polymer conjugates and process for preparing the same
IL113280A (en) * 1994-04-12 2004-12-15 Res Dev Foundation Composition for treating auto-immune diseases using type one interferons
JP2001511162A (en) * 1997-02-06 2001-08-07 ノボ ノルディスク アクティーゼルスカブ Appended, and / or polypeptide having the removed attachment group - polymer conjugates
EP1881005B1 (en) * 1997-07-14 2013-04-03 Bolder Biotechnology, Inc. Derivatives of G-CSF and related proteins
LT2599503T (en) * 1998-10-16 2017-06-26 Biogen Ma Inc. Polymer conjugates of interferon beta-1A and uses thereof

Also Published As

Publication number Publication date
HU0302674A2 (en) 2003-11-28
NO20020929D0 (en) 2002-02-26
MXPA02001969A (en) 2003-07-21
JP2003527090A (en) 2003-09-16
SK2942002A3 (en) 2002-08-06
CZ2002521A3 (en) 2002-05-15
WO2001015736A3 (en) 2003-05-22
BR0013638A (en) 2002-05-14
NO20020929L (en) 2002-04-25
AU6687000A (en) 2001-03-26
EP1328295A2 (en) 2003-07-23
WO2001015736A2 (en) 2001-03-08
CN1501815A (en) 2004-06-02
CA2380760A1 (en) 2001-03-08

Similar Documents

Publication Publication Date Title
DE60003001D1 (en) Pyrimidinverbindungen
DE60018571D1 (en) Hernienprothese
DE50014113D1 (en) Common-rail-injektor
DE50007809D1 (en) Brenner
DE60044881D1 (en) Nthalten
DE60008112D1 (en) Respiratorisches syncytialvirus replikation inhibitoren
DE60037335D1 (en) Polymerizationsverfahren
HK1074197A1 (en) Micro-granulose particulates
IL149623A (en) Inhaler
PL354143A1 (en) Novel uses
PT1795598E (en) Novel peptides
PT1272515E (en) Immunoregulator
GB9902023D0 (en) Directionally-controlled eccentric
IL132663A (en) Knowledge-engineering protocol-suite
PL354359A1 (en) New composition
AU3662101A (en) Cd40-binding apc-activating molecules
DE60027722D1 (en) Aspartyl-protease inhibitoren
DE60029235D1 (en) Fab-i-hemmer
PL364795A1 (en) New aminopropylphosphinic acids
AU8788201A (en) Nox-trap
GB9911943D0 (en) Improvements in lighting
GB0123381D0 (en) Factor
DE50011116D1 (en) Fucosyltransferase-gen
MXPA03007619A (en) New interferon beta-like molecules.
GB9922013D0 (en) Peptides